Sirtuins as Endogenous Regulators of Cardiac Fibrosis: A Current Perspective
Authors:
- 11 August 2025
- journal article
- Published by Springer Nature in Cardiovascular Toxicology
- Vol. 25 (10) , 1634-1649
Abstract
Cardiac fibrosis is a pathological condition marked by the excessive accumulation of extracellular matrix (ECM) components, which leads to impaired cardiac function and heart failure. Despite its significant contribution to cardiovascular morbidity and mortality, no effective therapeutic drugs specifically target the inhibition of cardiac fibrosis, largely due to the complex etiological heterogeneity and pathogenesis of this disease. Sirtuins (SIRTs), a family of NAD + -dependent deacetylases, play a critical role in cellular processes such as oxidative stress, inflammation, energy metabolism, mitochondrial function, epithelial-to-mesenchymal transition (EMT), and ECM homeostasis, all of which are implicated in cardiac fibrosis. Growing clinical and experimental evidence suggests that SIRTs regulate the cellular and molecular mechanisms of cardiomyocytes through various biological pathways. Emerging evidence indicates that sirtuin activators, including resveratrol and NAD + precursors, hold therapeutic potential in mitigating cardiac fibrosis. However, the complex and context-dependent roles of sirtuins necessitate further research to fully elucidate their mechanisms and translational applications. As the role of SIRTs in relation to cardiac fibrosis and its associated mechanisms is rarely discussed in the literature, this review comprehensively addresses the roles of the seven mammalian sirtuins (SIRT1-SIRT7) in the pathogenesis and progression of cardiac fibrosis. It highlights the key role of SIRTs as molecular targets for innovative anti-fibrotic therapies, offering new avenues for the treatment of cardiac fibrosis and associated cardiovascular diseases.Keywords
This publication has 111 references indexed in Scilit:
- SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylationNature, 2010
- From heterochromatin islands to the NAD World: A hierarchical view of aging through the functions of mammalian Sirt1 and systemic NAD biosynthesisBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in miceJournal of Clinical Investigation, 2009
- Sirt7 Increases Stress Resistance of Cardiomyocytes and Prevents Apoptosis and Inflammatory Cardiomyopathy in MiceCirculation Research, 2008
- SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic β CellsCell, 2006
- Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2Proceedings of the National Academy of Sciences, 2006
- Risk Factors of Postoperative Atrial Fibrillation After Cardiac SurgeryJournal of Cardiac Surgery, 2005
- Oxidative Stress During Myocardial Ischaemia and Heart FailureCurrent Pharmaceutical Design, 2004
- Phylogenetic Classification of Prokaryotic and Eukaryotic Sir2-like ProteinsBiochemical and Biophysical Research Communications, 2000
- Characterization of two genes required for the position‐effect control of yeast mating‐type genes.The EMBO Journal, 1984